Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Toms River, NJ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Endwell, NY
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Endwell, NY
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
New York, NY
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Schenectady, NY
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Schenectady, NY
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Greenville, NC
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Raleigh, NC
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Cleveland, OH
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Columbus, OH
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Medford, OR
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Portland, OR
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Columbia, SC
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Columbia, SC
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Mount Pleasant, SC
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Jackson, TN
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Jackson, TN
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Dallas, TX
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
San Antonio, TX
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Alexandria, VA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Alexandria, VA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Charlottesville, VA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Spokane, WA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Tacoma, WA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Walla Walla, WA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Wenatchee, WA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Wenatchee, WA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Coquitlam,
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Coquitlam,
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Jasper, AL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Phoenix, AZ
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Little Rock, AR
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Anaheim, CA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Greenwood, CO
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Greenwood, CO
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Wheat Ridge, CO
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Brandon, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Brandon, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Pembroke Pines, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
St. Petersburg, FL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Atlanta, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Austell, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Austell, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Macon, GA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Macon, GA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Elk Grove Village, IL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Normal, IL
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Danville, IN
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Danville, IN
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lenexa, KA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Topeka, KA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Topeka, KA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lexington, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Louisville, KY
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Lafayette, LA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Lafayette, LA
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Auburn, ME
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Auburn, ME
Click here to add this to my saved trials
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Brighton, MA
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Brighton, MA
Click here to add this to my saved trials